Gabapentin Capsule
Product Images NDC 68788-7848

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-7848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Capsules 300mg (civ)

Product description: Gabapentin Capsules 300mg, a generic drug for Neurontin produced by ScieGen Pharmaceuticals, Inc. The capsules are available in a package of unspecified size and lot number, and it is cautioned that the transfer of the product is prohibited by federal law. The label includes information on warnings, insurance, and a National Drug Code (NDC).*

FDA Label Image

Figure 1 (Image 01)

This appears to be a table or graph showing mean pain scores for a test group. The table includes different doses of a medication called "Parkod" (with both fixed and titrated doses) as well as a placebo and gabapentin at 3600 mg/day. The mean pain score is listed as 0 at baseline with weeks indicated, but without further context, the purpose or results of the test cannot be determined.*

FDA Label Image

Figure 2 (Image 02)

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.